thelancet.com
Dissection of blood–brain barrier dysfunction through CSF PDGFRβ and amyloid, tau, neuroinflammation, and synaptic CSF biomarkers in neurodegenerative disorders
CSF PDGFRβ, a candidate biomarker of BBB dysfunction, is increased in the early stages
of neurodegenerative disorders, in association with neuroinflammation and axonal and
synaptic damage.